Financhill
Buy
64

AXP Quote, Financials, Valuation and Earnings

Last price:
$368.70
Seasonality move :
4.65%
Day range:
$369.87 - $374.37
52-week range:
$220.43 - $387.49
Dividend yield:
0.85%
P/E ratio:
24.84x
P/S ratio:
3.29x
P/B ratio:
7.86x
Volume:
1.5M
Avg. volume:
2.5M
1-year change:
24.65%
Market cap:
$254.8B
Revenue:
$74.2B
EPS (TTM):
$14.89
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $38.2B $43.7B $55.6B $67.4B $74.2B
Revenue Growth (YoY) -18.79% 14.35% 27.39% 21.13% 10.12%
 
Cost of Revenues $11.8B $15.2B $20.1B $25.9B $28.8B
Gross Profit $26.4B $28.5B $35.5B $41.5B $45.4B
Gross Profit Margin 69.21% 65.3% 63.84% 61.63% 61.24%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $152M $767M -- -- $531M
Operating Expenses $20.7B $17B $24.5B $28.8B $30.4B
Operating Income $5.7B $11.5B $11B $12.7B $15B
 
Net Interest Expenses $1.2B $825M $1.2B $2B $2.6B
EBT. Incl. Unusual Items $4.3B $10.7B $9.6B $10.5B $12.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2B $2.6B $2.1B $2.1B $2.8B
Net Income to Company $3.1B $8.1B $7.5B $8.4B $10.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.1B $8B $7.5B $8.3B $10.1B
 
Basic EPS (Cont. Ops) $3.77 $10.03 $9.85 $11.23 $14.04
Diluted EPS (Cont. Ops) $3.77 $10.02 $9.84 $11.21 $14.02
Weighted Average Basic Share $805M $789M $751M $735M $712M
Weighted Average Diluted Share $806M $790M $752M $736M $713M
 
EBITDA $12B $11.8B $14.8B $19.3B $21.9B
EBIT $10.4B $10.1B $13.1B $17.6B $20.2B
 
Revenue (Reported) $38.2B $43.7B $55.6B $67.4B $74.2B
Operating Income (Reported) $5.7B $11.5B $11B $12.7B $15B
Operating Income (Adjusted) $10.4B $10.1B $13.1B $17.6B $20.2B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $11.2B $14.4B $17.2B $18.8B $20.6B
Revenue Growth (YoY) 22.11% 27.74% 19.78% 9.21% 9.54%
 
Cost of Revenues $4.2B $5.2B $6.5B $7.2B $7.9B
Gross Profit $7.1B $9.2B $10.7B $11.5B $12.7B
Gross Profit Margin 63.06% 63.78% 62.27% 61.49% 61.53%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $142M -$47M -- -- --
Operating Expenses $4.4B $6.3B $7.1B $7.6B $8.1B
Operating Income $2.6B $2.8B $3.6B $3.9B $4.6B
 
Net Interest Expenses $199M $356M $508M $693M $761M
EBT. Incl. Unusual Items $2.5B $2.5B $3.1B $3.2B $3.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $624M $580M $649M $697M $923M
Net Income to Company $1.8B $1.9B $2.5B $2.5B $2.9B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $1.8B $1.9B $2.4B $2.5B $2.9B
 
Basic EPS (Cont. Ops) $2.27 $2.47 $3.30 $3.49 $4.14
Diluted EPS (Cont. Ops) $2.27 $2.47 $3.30 $3.49 $4.14
Weighted Average Basic Share $786M $748M $732M $708M $692M
Weighted Average Diluted Share $787M $749M $733M $709M $693M
 
EBITDA $2.9B $4B $5.3B $5.7B $6.3B
EBIT $2.5B $3.6B $4.8B $5.3B $5.9B
 
Revenue (Reported) $11.2B $14.4B $17.2B $18.8B $20.6B
Operating Income (Reported) $2.6B $2.8B $3.6B $3.9B $4.6B
Operating Income (Adjusted) $2.5B $3.6B $4.8B $5.3B $5.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $41B $52.7B $65B $72.7B $78.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $14.1B $18.5B $24.9B $27.9B $30.6B
Gross Profit $26.8B $34.2B $40.1B $44.8B $48B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $810M -$74M -- $531M --
Operating Expenses $15.7B $23.1B $28.4B $30.2B $31.8B
Operating Income $11.1B $11B $11.7B $14.6B $16.2B
 
Net Interest Expenses $867M $994M $1.8B $2.5B $2.7B
EBT. Incl. Unusual Items $10.2B $10B $9.9B $12.7B $13.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.5B $2.4B $1.9B $2.8B $2.9B
Net Income to Company $7.8B $7.7B $8B $9.9B $10.5B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $7.7B $7.6B $8B $9.8B $10.5B
 
Basic EPS (Cont. Ops) $9.58 $9.97 $10.68 $13.61 $14.91
Diluted EPS (Cont. Ops) $9.56 $9.95 $10.67 $13.60 $14.89
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $11.2B $13.8B $17.9B $21.6B $23.1B
EBIT $9.5B $12.2B $16.2B $19.9B $21.3B
 
Revenue (Reported) $41B $52.7B $65B $72.7B $78.7B
Operating Income (Reported) $11.1B $11B $11.7B $14.6B $16.2B
Operating Income (Adjusted) $9.5B $12.2B $16.2B $19.9B $21.3B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $31.2B $40.2B $49.6B $55B $59.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.9B $14.3B $19.1B $21.2B $23.1B
Gross Profit $20.3B $25.9B $30.5B $33.8B $36.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) $774M -$68M -- $531M --
Operating Expenses $11.3B $17.4B $21.1B $22.2B $23.5B
Operating Income $9B $8.5B $9.4B $11.5B $12.8B
 
Net Interest Expenses $635M $804M $1.4B $1.9B $2.1B
EBT. Incl. Unusual Items $8.4B $7.7B $8B $10.1B $10.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2B $1.8B $1.6B $2.2B $2.3B
Net Income to Company $6.3B $5.9B $6.4B $8B $8.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.3B $5.9B $6.4B $7.9B $8.3B
 
Basic EPS (Cont. Ops) $7.82 $7.78 $8.60 $10.99 $11.87
Diluted EPS (Cont. Ops) $7.81 $7.77 $8.59 $10.97 $11.85
Weighted Average Basic Share $2.4B $2.3B $2.2B $2.1B $2.1B
Weighted Average Diluted Share $2.4B $2.3B $2.2B $2.1B $2.1B
 
EBITDA $8.8B $10.9B $14.1B $16.7B $18B
EBIT $7.5B $9.7B $12.9B $15.4B $16.6B
 
Revenue (Reported) $31.2B $40.2B $49.6B $55B $59.4B
Operating Income (Reported) $9B $8.5B $9.4B $11.5B $12.8B
Operating Income (Adjusted) $7.5B $9.7B $12.9B $15.4B $16.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $33B $22B $33.6B $46.6B $40.6B
Short Term Investments $21.6B $2.5B $4.5B $2.1B $953M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $76.4B $75.6B $91.3B $106.8B $99.9B
 
Property Plant And Equipment $5B $5B $5.2B $5.1B $6.2B
Long-Term Investments $23.4B $4.2B $6.4B $3.6B $3.7B
Goodwill $3.9B $3.8B $3.8B $3.9B $4.2B
Other Intangibles $265M $201M $146M $98M $123M
Other Long-Term Assets -- -- -- -- --
Total Assets $191.4B $188.5B $229.9B $262.5B $272.8B
 
Accounts Payable $9.4B $10.6B $12.1B $13.1B $13.9B
Accrued Expenses $1.4B $1.8B $2.1B $2.1B $2.1B
Current Portion Of Long-Term Debt $1.9B $2.2B $1.3B $1.3B $1.4B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $23.2B $27B $22B $24.8B $27.8B
 
Long-Term Debt $31.1B $24.5B $34.1B $37.5B $37.2B
Capital Leases -- -- -- -- --
Total Liabilities $168.4B $166.4B $205.2B $234.5B $242.6B
 
Common Stock $161M $153M $149M $145M $141M
Other Common Equity Adj -- -- -- -- --
Common Equity $23B $22.2B $24.7B $28.1B $30.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $23B $22.2B $24.7B $28.1B $30.3B
 
Total Liabilities and Equity $191.4B $188.5B $229.9B $262.5B $272.8B
Cash and Short Terms $33B $22B $33.6B $46.6B $40.6B
Total Debt $43B $38.7B $42.6B $47.9B $49.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $27.9B $31.2B $43.9B $47.9B $54.7B
Short Term Investments $8.5B $2.3B $2.8B $867M --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $76.6B $86.3B $102.6B $106.8B $115.5B
 
Property Plant And Equipment $5B $5.1B $5.1B $5.3B $5.9B
Long-Term Investments $10.1B $5.9B $3.6B $1.4B $1.6B
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $184.3B $214.9B $250.6B $271B $297.6B
 
Accounts Payable $9.6B $11B $13.2B $13.2B --
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $2.3B $1.5B $1.6B $1.5B --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $11.9B $12.5B $14.8B $14.6B $16.2B
 
Long-Term Debt $34.5B $42.4B $46.4B $53.5B $57.8B
Capital Leases -- -- -- -- --
Total Liabilities $159.8B $191B $223.3B $241.3B $265.1B
 
Common Stock $156M $150M $146M $141M $138M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity $734M -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $24.4B $23.9B $27.3B $29.7B $32.4B
 
Total Liabilities and Equity $184.3B $214.9B $250.6B $271B $297.6B
Cash and Short Terms $27.9B $31.2B $43.9B $47.9B $54.7B
Total Debt $34.5B $42.4B $46.4B $53.5B $57.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $3.1B $8.1B $7.5B $8.4B $10.1B
Depreciation & Amoritzation $1.5B $1.7B $1.6B $1.7B $1.7B
Stock-Based Compensation $249M $330M $375M $450M $504M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $5.6B $14.6B $21.1B $18.6B $14.1B
 
Capital Expenditures $1.5B $1.6B $1.9B $1.6B $1.9B
Cash Acquisitions $597M -- $15M $64M $454M
Cash From Investing $11.6B -$10.5B -$33.7B -$24.4B -$24.4B
 
Dividends Paid (Ex Special Dividend) $1.5B $1.4B $1.6B $1.8B $2B
Special Dividend Paid
Long-Term Debt Issued $69M $7.8B $23.2B $15.7B $12.6B
Long-Term Debt Repaid -$15.6B -$11.7B -$18.9B -$10.7B -$10.8B
Repurchase of Common Stock $1B $9.3B $3.5B $3.7B $6B
Other Financing Activities -- -- -- -- --
Cash From Financing -$9.1B -$14.9B $24.5B $18.4B $4.4B
 
Beginning Cash (CF) $32.8B $21.8B $33.3B $46.4B $40.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $8.5B -$10.9B $11.9B $12.7B -$6B
Ending Cash (CF) $41.7B $10.8B $45.2B $59.3B $34.4B
 
Levered Free Cash Flow $4.1B $13B $19.2B $17B $12.1B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.8B $1.9B $2.5B $2.5B $2.9B
Depreciation & Amoritzation $442M $413M $429M $437M $455M
Stock-Based Compensation $73M $84M $93M $113M $125M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4.2B $4.5B $8.2B -$1.8B $6.2B
 
Capital Expenditures $430M $444M $401M $457M $655M
Cash Acquisitions -- -- -- $90M --
Cash From Investing -$1.2B -$7.5B -$6.9B -$3.5B -$6.6B
 
Dividends Paid (Ex Special Dividend) $366M $407M $459M $516M $586M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $20M $6B $5B $4.2B --
Long-Term Debt Repaid -$2.8B -$4B -$5.4B -$3.2B --
Repurchase of Common Stock $4.1B $601M $1.4B $1.9B $2.4B
Other Financing Activities -- -- -- -- --
Cash From Financing -$5.9B $7.7B -$314M $350M -$3B
 
Beginning Cash (CF) $27.8B $30.2B $43.8B $47.8B $53.4B
Foreign Exchange Rate Adjustment $46M $205M -$51M $7M $91M
Additions / Reductions -$2.9B $4.9B $950M -$5B -$3.2B
Ending Cash (CF) $25B $35.3B $44.7B $42.8B $50.3B
 
Levered Free Cash Flow $3.7B $4.1B $7.8B -$2.3B $5.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $7.8B $7.7B $8B $9.9B $10.5B
Depreciation & Amoritzation $1.7B $1.6B $1.6B $1.7B $1.7B
Stock-Based Compensation $330M $356M $434M $502M $521M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $13.1B $17.7B $20.2B $15B $21.1B
 
Capital Expenditures $1.5B $1.9B $1.7B $1.8B $2.2B
Cash Acquisitions $597M $15M $64M $90M $997M
Cash From Investing -$4.8B -$34.2B -$27B -$20.3B -$25.2B
 
Dividends Paid (Ex Special Dividend) $1.5B $1.5B $1.7B $1.9B $2.2B
Special Dividend Paid
Long-Term Debt Issued $107M $28.5B $15.6B $15B --
Long-Term Debt Repaid -$10.1B -$20B -$11.6B -$8.8B --
Repurchase of Common Stock $5.5B $6.6B $3.4B $5.9B $5.9B
Other Financing Activities -- -- -- -- --
Cash From Financing -$16B $19.3B $19.9B $9.3B $10.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$7.7B $3.3B $12.7B $4B $6.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $11.6B $15.8B $18.6B $13.2B $18.9B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $6.3B $5.9B $6.4B $8B $8.4B
Depreciation & Amoritzation $1.3B $1.2B $1.2B $1.2B $1.3B
Stock-Based Compensation $256M $282M $341M $393M $410M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $9.6B $12.7B $11.8B $8.3B $15.4B
 
Capital Expenditures $1.1B $1.3B $1.1B $1.4B $1.7B
Cash Acquisitions -- $15M $64M $90M $633M
Cash From Investing $793M -$22.9B -$16.3B -$12.2B -$12.9B
 
Dividends Paid (Ex Special Dividend) $1.1B $1.2B $1.3B $1.5B $1.7B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $38M $20.7B $13.1B $12.5B $15.9B
Long-Term Debt Repaid -$8.2B -$16.5B -$9.3B -$7.4B -$7.9B
Repurchase of Common Stock $5.5B $2.9B $2.7B $5B $4.9B
Other Financing Activities -- -- -- -- --
Cash From Financing -$15.3B $18.9B $14.3B $5.2B $11.4B
 
Beginning Cash (CF) $97.2B $81.7B $126.7B $154.6B $163.4B
Foreign Exchange Rate Adjustment -$181M $489M $156M $1M $285M
Additions / Reductions -$5B $9.2B $10B $1.3B $14.1B
Ending Cash (CF) $92B $91.3B $136.9B $156B $177.8B
 
Levered Free Cash Flow $8.6B $11.3B $10.6B $6.9B $13.7B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 8.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock